- Benefit
- National health insurance support for continuous glucose monitors and automatic insulin infusion devices, previously available only to type 1 diabetes patients, is being expanded to about 11,000 people with severe type 2 diabetes such as pancreatic impairment and islet failure. The level of insulin pump support for ages 19-34 will be made the same as for children. Savings of about KRW 4,180,000 per year.
- Who is eligible
- Type 1 diabetes and severe type 2 diabetes patients such as pancreatic impairment and islet failure (check detailed criteria in the official notice)
- When to apply
- Implemented after the official notice (timing not fixed)
- How to apply
- Prescription at a treating medical institution and national health insurance benefit claim (after the official notice)
- Important notes
- Not applicable before implementation. Check Ministry of Health and Welfare and NHIS notices
- Note
- Announced following a Health Insurance Policy Deliberation Committee resolution on September 8, 2026. Exact implementation date and benefit criteria are unconfirmed.
Based on official sources as of 2026년 10월. Amounts and requirements may change, so please confirm with the official guide before applying.